$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the common side effects of tofacitinib? How to reduce the occurrence of adverse reactions and ensure treatment effectiveness?
2026-02-01 22:25:32
Check Details
Can I stop taking cycloserine once I start taking it? If the drug needs to be discontinued, how should the dose be gradually reduced?
2026-02-01 22:25:32
Check Details
Which is better, linezolid or vancomycin? What are the main differences and applicable scenarios between the two in treatment?
2026-02-01 22:25:32
Check Details
Is ribociclib already included in medical insurance? How is it reimbursed by medical insurance?
2026-02-01 22:25:32
Check Details
What drug is cimepilimab? What are its principles of action and therapeutic indications?
2026-02-01 22:25:32
Check Details
What precautions should be taken when using daprestat? Are there any contraindications or behaviors to avoid?
2026-02-01 22:25:32
Check Details
Is zotuximab available for purchase in the country? Are there relevant purchasing channels and methods?
2026-02-01 22:25:32
Check Details
What key information does the durvalumab (durvalumab) package insert contain? What should you pay attention to when using it?
2026-02-01 22:25:32
Check Details
What is 0.01% Atropine Sulfate Eye Drops? How does it help control myopia?
2026-02-01 22:25:32
Check Details
What is the latest price of Avonib in 2025? Introduction to domestic and foreign market prices and purchasing methods
2026-02-01 22:25:32
Check Details
Is mitotane a chemotherapy drug or a targeted drug? What kind of anti-cancer method does its treatment mechanism belong to?
2026-02-01 22:25:32
Check Details
Can pemetinib extend life? Improvements in survival shown by clinical trial data
2026-02-01 22:25:32
Check Details
1
2
...
1354
1355
1356
1357
1358
1359
1360
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure